Interferon-α and interferon-γ sensitize human tenon fibroblasts to mitomycin-C

被引:12
|
作者
Wang, Xiao Yang
Crowston, Jonathan G.
Zoellner, Hans
Healey, Paul R.
机构
[1] Univ Sydney, Ctr Vis Res, Westmead Millennium Res Inst, Westmead Hosp, Sydney, NSW 2006, Australia
[2] Univ Melbourne, Ctr Eye Res Australia, East Melbourne, Australia
[3] Univ Sydney, Dept Oral Med & Oral Pathol, Cellular & Mol Res Unit, Sydney, NSW 2006, Australia
关键词
D O I
10.1167/iovs.06-1121
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. To investigate the effect of interferon (IFN)-alpha and IFN-alpha pretreatment on mitomycin C (MMC)-induced cell death in human Tenon fibroblasts (HTFs) and the mechanisms by which IFN-alpha and IFN-alpha modulate the susceptibility of HTFs to MMC. METHODS. HTFs were pretreated with IFN-alpha and IFN-alpha for 48 hours before 5-minute application of 0.4 mg/mL MMC. Cell death after 48 hours was determined by Annexin V/propidium iodide ( PI) staining and lactate dehydrogenase (LDH) release assay. Fas, Fas-ligand, and Bcl-2 expression were determined by flow cytometry. Fas associated death domain (FADD), Bax, cytochrome c, and caspase expression were determined by Western blot analysis and immunofluorescence staining. RESULTS. MMC treatment increased cell death and upregulated Fas and FADD expression, but had no effect on Fas-Ligand, Bax, Bcl-2, or cytochrome c. Neither IFN-alpha nor IFN-alpha alone induced HTF death, but each increased cell death 2 days after MMC treatment in a dose-dependent fashion. Combination IFN-alpha and IFN-gamma had a synergistic effect. IFN-alpha and IFN-gamma pretreatment increased Fas expression. Fas upregulation was associated with increased sensitivity to MMC. IFN pretreatment increased procaspase-8, procaspase-9, and procaspase-3 expression, and caspase-3 activation. Caspase-8, caspase-3, and broad caspase inhibitors, but not caspase-9 inhibitor, inhibited MMC-induced cell death in nonpretreated and IFN-pretreated cells. CONCLUSIONS. IFN-alpha and IFN-alpha enhance the susceptibility of HTFs to MMC-induced cell death through a Fas-mediated and a caspase-3-dependent pathway. Pretreatment with IFN primed HTFs to MMC, providing a potential means for initially slowing the healing response with IFN and subsequently terminating fibroblast activity through MMC-induced cell death.
引用
收藏
页码:3655 / 3661
页数:7
相关论文
共 50 条
  • [1] Interferon-β is required for interferon-α production in mouse fibroblasts
    Erlandsson, L
    Blumenthal, R
    Eloranta, ML
    Engel, H
    Alm, G
    Weiss, S
    Leanderson, T
    [J]. CURRENT BIOLOGY, 1998, 8 (04) : 223 - 226
  • [3] Interferon-β and Interferon-λ Signaling Is Not Affected by Interferon-Induced Refractoriness to Interferon-α In Vivo
    Makowska, Zuzanna
    Duong, Francois H. T.
    Trincucci, Gaia
    Tough, David F.
    Heim, Markus H.
    [J]. HEPATOLOGY, 2011, 53 (04) : 1154 - 1163
  • [4] Differential Transcriptional Responses to Interferon-α and Interferon-γ in Primary Human Hepatocytes
    He, Xiao-Song
    Nanda, Santosh
    Ji, Xuhuai
    Calderon-Rodriguez, Gloria M.
    Greenberg, Harry B.
    Liang, T. Jake
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2010, 30 (05): : 311 - 320
  • [5] Inhibition of eotaxin expression in human corneal fibroblasts by interferon-γ
    Fukuda, K
    Yamada, N
    Fujitsu, Y
    Kumagai, N
    Nishida, T
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 129 (02) : 138 - 144
  • [6] Interferon-γ and human megakaryopoiesis
    Tsuji, K
    Muraoka, K
    Nakahata, T
    [J]. LEUKEMIA & LYMPHOMA, 1998, 31 (1-2) : 107 - 113
  • [7] Interferon-α in Hepatitis C
    Raymond S. Koff
    [J]. PharmacoEconomics, 1997, 11 : 491 - 491
  • [8] Proteasome response to interferon-γ is altered in senescent human fibroblasts
    Stratford, Fiona L. L.
    Chondrogianni, Niki
    Trougakos, Ioannis P.
    Gonos, Efstathios S.
    Rivett, A. Jennifer
    [J]. FEBS LETTERS, 2006, 580 (16) : 3989 - 3994
  • [9] Interferon-α alone versus interferon-α plus ribavirin in patients with chronic hepatitis C not responding to previous interferon-α treatment
    Tripi, S
    Di Gaetano, G
    Soresi, M
    Cartabellotta, F
    Vassallo, R
    Carroccio, A
    Anastasi, G
    Montalto, G
    [J]. BIODRUGS, 2000, 13 (04) : 299 - 304
  • [10] Attenuated expression of interferon-β and interferon-λl by human alternatively activated macrophages
    El Fiky, Ashraf
    Perreault, Roger
    McGinnis, Gwendolyn J.
    Rabin, Ronald L.
    [J]. HUMAN IMMUNOLOGY, 2013, 74 (12) : 1524 - 1530